INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 16, 2011 |
SVP Finance and Admin CFO Trea
Trans History: 645
|
SVP Finance and Admin CFO Trea | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 56,250 | -- | 87,798 |
| Dec 16, 2011 |
SVP Finance and Admin CFO Trea
Trans History: 645
|
SVP Finance and Admin CFO Trea | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 38,079 | -- | 38,079 |
| Dec 16, 2011 |
SVP Gen Counsel and Secretary
Trans History: 181
|
SVP Gen Counsel and Secretary | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,000 | -- | 4,000 |
| Dec 16, 2011 |
VP Controller and Asst Treasur
Trans History: 372
|
VP Controller and Asst Treasur | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,921 | -- | 1,921 |
| Dec 16, 2011 |
VP Controller and Asst Treasur
Trans History: 372
|
VP Controller and Asst Treasur | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 21,579 | -- | 21,579 |
| Dec 16, 2011 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,921 | -- | 1,921 |
| Dec 16, 2011 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 45,000 |
| Dec 16, 2011 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,079 | -- | 30,079 |
| Dec 16, 2011 |
VP Regulatory Development and
Trans History: 288
|
VP Regulatory Development and | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,921 | -- | 1,921 |
| Dec 16, 2011 |
VP Regulatory Development and
Trans History: 288
|
VP Regulatory Development and | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 28,079 | -- | 28,079 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.